Company: MIRM
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001759425-25-000014
Chunk: 130

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 5
Chunk 130
---
 do not make or endorse any predictions as to future stockholder returns.

COMPARISON OF CUMULATIVE TOTAL RETURN

among Mirum Pharmaceuticals, Inc., the NASDAQ Composite Index and the NASDAQ Biotech Index

$100 Investment in Stock or Index12/31/201912/31/202012/31/202112/31/202212/31/202312/31/2024Mirum Pharmaceuticals, Inc.$100.00 $71.21 $65.05 $79.53 $120.39 $168.64 NASDAQ Composite Index$100.00 $143.64 $174.36 $116.65 $167.30 $215.22 NASDAQ Biotechnology Index$100.00 $125.69 $124.89 $111.27 $115.42 $113.84 

Recent Sales of Unregistered Securities

There were no sales of equity securities during the period covered by this report that were not registered under the Securities Act and were not previously reported in a Quarterly Report on Form 10-Q or a Current Report on Form 8-K filed by the Company.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

None.